MediWound (MDWD) News Today $20.62 -0.67 (-3.15%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$20.62 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDWD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Brokerages Set MediWound Ltd. (NASDAQ:MDWD) Target Price at $31.25June 5, 2025 | americanbankingnews.comMediWound Ltd. (NASDAQ:MDWD) Shares Acquired by Silverberg Bernstein Capital Management LLCSilverberg Bernstein Capital Management LLC grew its stake in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 13.1% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 103,944 shares of the biopharmaceutJune 3, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Now Covered by Analysts at OppenheimerJune 3, 2025 | americanbankingnews.comCompanies Like MediWound (NASDAQ:MDWD) Are In A Position To Invest In GrowthJune 2, 2025 | finance.yahoo.comMediWound Ltd. (NASDAQ:MDWD) Given Average Rating of "Buy" by AnalystsShares of MediWound Ltd. (NASDAQ:MDWD - Get Free Report) have received an average recommendation of "Buy" from the four brokerages that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a buy rating. The average 12-month price target among analysJune 2, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Coverage Initiated at OppenheimerOppenheimer initiated coverage on MediWound in a report on Monday. They set an "outperform" rating and a $34.00 price objective on the stock.June 2, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for MediWound Q2 Earnings?MediWound Ltd. (NASDAQ:MDWD - Free Report) - Stock analysts at HC Wainwright upped their Q2 2025 earnings per share estimates for MediWound in a research note issued on Thursday, May 22nd. HC Wainwright analyst S. Ramakanth now expects that the biopharmaceutical company will post earnings of ($0.May 27, 2025 | marketbeat.comNorthern Trust Corp Has $2.58 Million Holdings in MediWound Ltd. (NASDAQ:MDWD)Northern Trust Corp lifted its holdings in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 94.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 144,768 shares of the biopharmaceutical company's stock aftMay 26, 2025 | marketbeat.comHC Wainwright Forecasts Strong Price Appreciation for MediWound (NASDAQ:MDWD) StockHC Wainwright lifted their price objective on shares of MediWound from $25.00 to $31.00 and gave the stock a "buy" rating in a research report on Thursday.May 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Stock Crosses Above Fifty Day Moving Average - What's Next?MediWound (NASDAQ:MDWD) Stock Passes Above Fifty Day Moving Average - Time to Sell?May 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Releases Earnings Results, Beats Estimates By $0.58 EPSMediWound (NASDAQ:MDWD - Get Free Report) issued its quarterly earnings results on Wednesday. The biopharmaceutical company reported ($0.07) EPS for the quarter, topping the consensus estimate of ($0.65) by $0.58. MediWound had a negative net margin of 142.29% and a negative return on equity of 82.17%. During the same quarter in the previous year, the firm posted ($1.05) EPS.May 23, 2025 | marketbeat.comMediWound’s Q1 2025: Strategic Progress Amid Financial ChallengesMay 22, 2025 | tipranks.comMediWound (MDWD) Q1 2025 Earnings Call TranscriptMay 21, 2025 | msn.comMediWound Ltd. (MDWD) Q1 2025 Earnings Call TranscriptMay 21, 2025 | seekingalpha.comMediWound Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 21, 2025 | globenewswire.comMediWound Q1 2025 Earnings PreviewMay 20, 2025 | msn.comMediWound Ltd.: Undervalued High-Growth PotentialMay 16, 2025 | seekingalpha.comMediWound (MDWD) to Release Earnings on WednesdayMediWound (NASDAQ:MDWD) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-21-mediwound-ltd-stock/)May 16, 2025 | marketbeat.comMediWound Announces Publication of Phase II EscharEx® Data Demonstrating Superiority Over Collagenase in Venous Leg UlcersMay 13, 2025 | globenewswire.comMediWound Ltd. (NASDAQ:MDWD) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC lowered its position in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 66.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,418 shares of the bMay 9, 2025 | marketbeat.comMediWound to Report First Quarter 2025 Financial ResultsMay 5, 2025 | globenewswire.comMediWound (NASDAQ:MDWD) Earns Buy Rating from Analysts at Alliance Global PartnersAlliance Global Partners initiated coverage on shares of MediWound in a research report on Friday. They issued a "buy" rating and a $25.00 price target for the company.May 4, 2025 | marketbeat.comMediWound to Present New EscharEx® Data at Leading Wound Care ConferencesApril 28, 2025 | globenewswire.comMediWound (NASDAQ:MDWD) Stock Price Passes Above 50 Day Moving Average - Here's WhyMediWound (NASDAQ:MDWD) Stock Price Crosses Above Fifty Day Moving Average - Here's What HappenedApril 27, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Shares Cross Below 200-Day Moving Average - Time to Sell?MediWound (NASDAQ:MDWD) Stock Crosses Below 200-Day Moving Average - Here's What HappenedApril 19, 2025 | marketbeat.comThose who invested in MediWound (NASDAQ:MDWD) five years ago are up 30%April 17, 2025 | finance.yahoo.comMediWound (NASDAQ:MDWD) Stock Passes Below 200 Day Moving Average - Here's WhyMediWound (NASDAQ:MDWD) Stock Passes Below Two Hundred Day Moving Average - Time to Sell?April 11, 2025 | marketbeat.comHC Wainwright Has Bearish Estimate for MediWound Q1 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Research analysts at HC Wainwright lowered their Q1 2025 earnings per share estimates for shares of MediWound in a research report issued to clients and investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now expects that the biopharmMarch 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Upgraded to Sell at StockNews.comStockNews.com upgraded MediWound to a "sell" rating in a research report on Friday.March 22, 2025 | marketbeat.comAnalysts Offer Predictions for MediWound FY2029 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Analysts at HC Wainwright issued their FY2029 earnings estimates for MediWound in a note issued to investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth forecasts that the biopharmaceutical company will earn $2.45 per share for the yearMarch 22, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Earns "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $25.00 price objective on shares of MediWound in a report on Thursday.March 21, 2025 | marketbeat.comMediWound reports Q4 EPS (36c), consensus (61c)March 20, 2025 | markets.businessinsider.comMediWound files $125M mixed securities shelfMarch 20, 2025 | markets.businessinsider.comLoss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-TermMarch 20, 2025 | finance.yahoo.comMediWound (NASDAQ:MDWD) Posts Earnings Results, Beats Estimates By $0.25 EPSMediWound (NASDAQ:MDWD - Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.61) by $0.25. MediWound had a negative net margin of 142.29% and a negative return on equity of 82.17%. During the same period last year, the company posted ($0.19) EPS.March 20, 2025 | marketbeat.comMediWound Ltd. (MDWD) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comMediWound Reports 2024 Financials and Strategic AdvancesMarch 19, 2025 | tipranks.comMediWound shares rise as Q4 loss is narrower than expectedMarch 19, 2025 | investing.comMediWound Reports 2024 Financial Results and Strategic AdvancesMarch 19, 2025 | tipranks.comMediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 19, 2025 | globenewswire.comMediWound Q4 2024 Earnings PreviewMarch 18, 2025 | msn.comMediwound (MDWD) Receives a New Rating from Craig-HallumMarch 17, 2025 | markets.businessinsider.comMediWound (MDWD) Projected to Post Earnings on WednesdayMediWound (NASDAQ:MDWD) will be releasing earnings before the market opens on Wednesday, March 19, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=671988)March 12, 2025 | marketbeat.comEssex Investment Management Co. LLC Acquires 35,012 Shares of MediWound Ltd. (NASDAQ:MDWD)Essex Investment Management Co. LLC raised its holdings in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 30.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,949 shares of the biopharmaceutical company's stock aftMarch 10, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Stock Passes Below 200 Day Moving Average - Time to Sell?MediWound (NASDAQ:MDWD) Stock Crosses Below 200-Day Moving Average - What's Next?March 8, 2025 | marketbeat.comMediWound to Report Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comMediWound (NASDAQ:MDWD) Now Covered by Analysts at Craig HallumCraig Hallum started coverage on shares of MediWound in a research report on Friday. They issued a "buy" rating and a $39.00 target price on the stock.March 1, 2025 | marketbeat.comMediWound Ltd. (NASDAQ:MDWD) Stock Position Boosted by Yelin Lapidot Holdings Management Ltd.Yelin Lapidot Holdings Management Ltd. grew its stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 851,361 shares of the biopharmaceuticaMarch 1, 2025 | marketbeat.comCraig-Hallum starts MediWound with Buy on EscharEx potentialMarch 1, 2025 | markets.businessinsider.comMediWound initiated with a Buy at Craig-HallumMarch 1, 2025 | markets.businessinsider.com Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address MDWD Media Mentions By Week MDWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDWD News Sentiment▼0.930.87▲Average Medical News Sentiment MDWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDWD Articles This Week▼12▲MDWD Articles Average Week Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies uniQure News Praxis Precision Medicines News Ardelyx News LENZ Therapeutics News Oculis News Zymeworks News Intellia Therapeutics News Nuvation Bio News ArriVent BioPharma News Immunome News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDWD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
